Ingrid Langer

1.2k total citations
53 papers, 987 citations indexed

About

Ingrid Langer is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Ingrid Langer has authored 53 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 37 papers in Cellular and Molecular Neuroscience and 18 papers in Oncology. Recurrent topics in Ingrid Langer's work include Receptor Mechanisms and Signaling (37 papers), Neuropeptides and Animal Physiology (37 papers) and Peptidase Inhibition and Analysis (16 papers). Ingrid Langer is often cited by papers focused on Receptor Mechanisms and Signaling (37 papers), Neuropeptides and Animal Physiology (37 papers) and Peptidase Inhibition and Analysis (16 papers). Ingrid Langer collaborates with scholars based in Belgium, France and Poland. Ingrid Langer's co-authors include Patrick Robberecht, Jason Perret, Pascale Vertongen, Magalì Waelbroeck, Irina G. Tikhonova, Daniel Fourmy, Jeanine Fontaine, Christelle Langlet, Chantal Escrieut and Ghanem Atassi and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Biochemical Journal.

In The Last Decade

Ingrid Langer

52 papers receiving 960 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingrid Langer Belgium 20 644 553 164 132 91 53 987
André Laperrière Canada 9 1.1k 1.6× 454 0.8× 62 0.4× 48 0.4× 65 0.7× 9 1.3k
Muriel Nobles United Kingdom 22 1.0k 1.6× 339 0.6× 99 0.6× 36 0.3× 85 0.9× 38 1.5k
Rachel Davis‐Taber United States 14 506 0.8× 243 0.4× 103 0.6× 54 0.4× 234 2.6× 19 821
Normand McNicoll Canada 21 771 1.2× 216 0.4× 102 0.6× 257 1.9× 29 0.3× 34 1.4k
Matthew Hardwick United States 11 374 0.6× 224 0.4× 121 0.7× 58 0.4× 47 0.5× 16 770
Jialu Wang China 13 628 1.0× 231 0.4× 48 0.3× 58 0.4× 50 0.5× 25 830
Robert George United States 14 530 0.8× 235 0.4× 158 1.0× 24 0.2× 72 0.8× 28 1.1k
J. D. Gardner United States 21 635 1.0× 792 1.4× 225 1.4× 155 1.2× 23 0.3× 39 1.1k
Mei Zheng South Korea 18 622 1.0× 297 0.5× 81 0.5× 25 0.2× 44 0.5× 49 969
Zhiyu Yang Australia 17 286 0.4× 87 0.2× 86 0.5× 74 0.6× 42 0.5× 41 701

Countries citing papers authored by Ingrid Langer

Since Specialization
Citations

This map shows the geographic impact of Ingrid Langer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Langer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Langer more than expected).

Fields of papers citing papers by Ingrid Langer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Langer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Langer. The network helps show where Ingrid Langer may publish in the future.

Co-authorship network of co-authors of Ingrid Langer

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Langer. A scholar is included among the top collaborators of Ingrid Langer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Langer. Ingrid Langer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosière, Rémi, Myriam Remmelink, Ingrid Langer, et al.. (2021). Pulmonary and renal tolerance of cisplatin-based regimens combining intravenous and endotracheal routes for lung cancer treatment in mice. International Journal of Pharmaceutics. 599. 120425–120425. 5 indexed citations
2.
Langer, Ingrid & Dorota Latek. (2021). Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors. Frontiers in Endocrinology. 12. 711906–711906. 8 indexed citations
3.
Yates, Andrew, et al.. (2014). Stability study of full-length antibody (anti-TNF alpha) loaded PLGA microspheres. International Journal of Pharmaceutics. 470(1-2). 41–50. 38 indexed citations
4.
Langer, Ingrid. (2011). Conformational switches in the VPAC1receptor. British Journal of Pharmacology. 166(1). 79–84. 7 indexed citations
5.
Chugunov, Anton O., John Simms, David R. Poyner, et al.. (2010). Evidence that Interaction between Conserved Residues in Transmembrane Helices 2, 3, and 7 Are Crucial for Human VPAC1 Receptor Activation. Molecular Pharmacology. 78(3). 394–401. 27 indexed citations
6.
Langer, Ingrid, et al.. (2008). Cell surface targeting of VPAC1 receptors: Evidence for implication of a quality control system and the proteasome. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1783(9). 1663–1672. 8 indexed citations
7.
Langer, Ingrid, Irina G. Tikhonova, Cyril Boulègue, et al.. (2008). Evidence for a Direct and Functional Interaction between the Regulators of G Protein Signaling-2 and Phosphorylated C Terminus of Cholecystokinin-2 Receptor. Molecular Pharmacology. 75(3). 502–513. 14 indexed citations
8.
Tikhonova, Irina G., et al.. (2007). Validated Ligand Binding Sites in CCK Receptors. Next Step: Computer-Aided Design of Novel CCK Ligands. Current Topics in Medicinal Chemistry. 7(12). 1243–1247. 8 indexed citations
9.
Langer, Ingrid, et al.. (2006). Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2). British Journal of Pharmacology. 148(8). 1051–1059. 17 indexed citations
10.
Tikhonova, Irina G., Cyril Boulègue, Ingrid Langer, & Daniel Fourmy. (2006). Modeled structure of the whole regulator G-protein signaling-2. Biochemical and Biophysical Research Communications. 341(3). 715–720. 8 indexed citations
11.
Langer, Ingrid, Irina G. Tikhonova, Marie‐Agnès Travers, et al.. (2005). Evidence That Interspecies Polymorphism in the Human and Rat Cholecystokinin Receptor-2 Affects Structure of the Binding Site for the Endogenous Agonist Cholecystokinin. Journal of Biological Chemistry. 280(23). 22198–22204. 25 indexed citations
12.
Langer, Ingrid, Christelle Langlet, & Patrick Robberecht. (2005). Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptor. Journal of Molecular Endocrinology. 34(2). 405–414. 19 indexed citations
13.
Langlet, Christelle, et al.. (2004). Comparative efficacy of VIP and analogs on activation and internalization of the recombinant VPAC2 receptor expressed in CHO cells. Peptides. 25(12). 2079–2086. 16 indexed citations
14.
15.
Langer, Ingrid, P. Vertongen, Jason Perret, Magalì Waelbroeck, & Patrick Robberecht. (2003). Lysine 195 and aspartate 196 in the first extracellular loop of the VPAC1 receptor are essential for high affinity binding of agonists but not of antagonists. Neuropharmacology. 44(1). 125–131. 8 indexed citations
16.
Perret, Jason, P. Vertongen, Rosa M. Solano, et al.. (2002). Two tyrosine residues in the first transmembrane helix of the human vasoactive intestinal peptide receptors play a role in supporting the active conformation. British Journal of Pharmacology. 136(7). 1042–1048. 6 indexed citations
17.
Langer, Ingrid, Jason Perret, P. Vertongen, Magalì Waelbroeck, & Patrick Robberecht. (2001). Vasoactive intestinal peptide (VIP) stimulates [Ca2+]iand cyclic AMPin CHO cells expressing Gα16. Cell Calcium. 30(4). 229–234. 22 indexed citations
18.
Solano, Rosa M., Ingrid Langer, Jason Perret, et al.. (2001). Two Basic Residues of the h-VPAC1 Receptor Second Transmembrane Helix Are Essential for Ligand Binding and Signal Transduction. Journal of Biological Chemistry. 276(2). 1084–1088. 76 indexed citations
19.
Petr, Jan, et al.. (2000). Quality of malting barley grown under different cultivation systems.. 53. 90–94. 7 indexed citations
20.
Langer, Ingrid, Pascale Vertongen, Jason Perret, et al.. (2000). Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomas. Medical and Pediatric Oncology. 34(6). 386–393. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by André Laperrière Breakdown of academic impact, for papers by Muriel Nobles Breakdown of academic impact, for papers by Rachel Davis‐Taber Breakdown of academic impact, for papers by Normand McNicoll Breakdown of academic impact, for papers by Matthew Hardwick Breakdown of academic impact, for papers by Jialu Wang Breakdown of academic impact, for papers by Robert George Breakdown of academic impact, for papers by J. D. Gardner Breakdown of academic impact, for papers by Mei Zheng Breakdown of academic impact, for papers by Zhiyu Yang
Rankless by CCL
2026